Matches in Nanopublications for { ?s ?p "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP291586.RAy_I9XQAcWe0WfZkGqxiU-fEn8mEWtdMO191qWmBvIoA130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291586.RAy_I9XQAcWe0WfZkGqxiU-fEn8mEWtdMO191qWmBvIoA130_provenance.
- NP495119.RAB2arO-BXqsubWenzT7Y3cxkBz2QzgRM4JgcGE6-fmIU130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495119.RAB2arO-BXqsubWenzT7Y3cxkBz2QzgRM4JgcGE6-fmIU130_provenance.
- NP335445.RAXULEfPguF-vx6nqbWE0fpOztE6UbjeXbUfQy09ldDnU130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335445.RAXULEfPguF-vx6nqbWE0fpOztE6UbjeXbUfQy09ldDnU130_provenance.
- assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP911227.RAV40oFO8RqU1InQ19RuTMZIIDyE0I6uTsPmtbwCdVrQs130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911227.RAV40oFO8RqU1InQ19RuTMZIIDyE0I6uTsPmtbwCdVrQs130_provenance.
- assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP495121.RA0TQxNUgiaAjChnaUCUFfGo6SYZqA5dz9l9M9hkaRvd4130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495121.RA0TQxNUgiaAjChnaUCUFfGo6SYZqA5dz9l9M9hkaRvd4130_provenance.
- NP291002.RAG8_8lO5e9QYwCPtNaE-WVK0GCrXx6dLrgyuUxtgnzhE130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291002.RAG8_8lO5e9QYwCPtNaE-WVK0GCrXx6dLrgyuUxtgnzhE130_provenance.
- NP495122.RAZrc_BJvTpn8LRjZTVE9nPC5KjlLgFPm9wPL0MeCoa_o130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495122.RAZrc_BJvTpn8LRjZTVE9nPC5KjlLgFPm9wPL0MeCoa_o130_provenance.
- assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP495120.RAN4qdO4NKppNwhgD0VKBl6b0_VXtvDwxzlPtXvEl9xT4130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495120.RAN4qdO4NKppNwhgD0VKBl6b0_VXtvDwxzlPtXvEl9xT4130_provenance.
- NP495124.RAiM2b4xSAPPTxxbV_h9vU9_y4rZKAZF4-EQMPb651vq8130_assertion description "[The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56(-) and CD117(-) cases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495124.RAiM2b4xSAPPTxxbV_h9vU9_y4rZKAZF4-EQMPb651vq8130_provenance.